The TARC/sICAM5 ratio in patient plasma is a candidate biomarker for drug resistant epilepsy

by John R. Pollard, Ofer eEidelman, Gregory P. Mueller, Clifton L. Dalgard, Peter B. Crino, Christopher T. Anderson, Elizabeth J. Brand, Evren eBurakgazi-Dalkilic, Sai K. Ivaturi, Harvey B. Pollard
Published 2013-01-01